United States· US:0404-9966_9cf73167-0981-4239-9e5f-b026816fa9f8
Verapamil Hydrochloride
A medicinal product containing verapamil hydrochloride, registered in United States by Henry Schein, Inc..
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- Verapamil Hydrochloride
- Manufacturer
- Henry Schein, Inc.
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 12, 2026
Packs & prices · 1
- ndc1104049966021 VIAL, SINGLE-DOSE in 1 BAG (0404-9966-02) / 2 mL in 1 VIAL, SINGLE-DOSE
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Verapamil hydrochloride in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaISOCOR
- FinlandVeramacorMacure Pharma ApS
- IrelandIsoptin 2.5 mg/ml Solution for Injection or InfusionViatris Healthcare Limited
- NorwayVeramacorMacure Pharma ApS
- SwedenVeramacor 2,5 mg/ml Injektions-/infusionsvätska, lösningMACURE PHARMA ApS
- United KingdomCordilox 120mg tabletsIVAX Pharmaceuticals UK Ltd
- PolandIsoptin 40Medezin Sp. z o.o.
- GermanyIsoptinViatris Healthcare Gmbh
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Isoptin, Isoptin Retard
- Belgium · Fibrocard, Isoptine
- Bulgaria · Верапамил Софарма, Верапамил Чайкафарма
- Cyprus · Akilen, Caveril
- Czechia · Isoptin, Isoptin Sr
- Germany · Isoptin, Isoptin Khk Retard
- Denmark · Isoptin Retard, Veraloc
- Estonia · Isoptin Retard, Verapamil Ratiopharm
- Spain · Manidón, Manidón Hta
- Finland · Isoptin Retard, Veramacor
- France · Isoptine, Isoptine L.P.
- United Kingdom (Northern Ireland) · Half Securon Sr, Securon Sr
- Greece · Isoptin
- Croatia · Isoptin, Isoptin Rr
- Hungary · Chinopamil, Isoptin
- Ireland · Isoptin, Isoptin Sr
- Iceland · Isoptin Retard, Veraloc Retard
- Italy · Isoptin, Verapamil Doc Generici
- Lithuania · Isoptin Retard, Verapamil Ratiopharm
- Luxembourg · Isoptin, Isoptin Khk Retard
- Latvia · Isoptin Retard
- Malta · Caveril, Isoptin
- Netherlands · Isoptin Sr, Verapamil Hcl Cf
- Norway · Isoptin, Isoptin Retard
- Poland · Isoptin 40, Isoptin 80
- Portugal · Isoptin, Isoptin Dc
- Romania · Cordamil, Isoptin Rr
- Sweden · Isoptin, Isoptin Retard
- Slovakia · Isoptin, Isoptin Ichs Retard
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ccefddb3-47b6-40cd-803e-a6d27bc3af56 GET /v1/drugs/ccefddb3-47b6-40cd-803e-a6d27bc3af56?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "INTRAVENOUS",
"livertox": {
"summary": null,
"livertox_id": null,
"hepatotoxicity_score": 2
},
"productid": "0404-9966_9cf73167-0981-4239-9e5f-b026816fa9f8",
"productndc": "0404-9966",
"dosage_form": "INJECTION, SOLUTION",
"dea_schedule": null,
"product_type": "HUMAN PRESCRIPTION DRUG",
"substance_name": "VERAPAMIL HYDROCHLORIDE",
"proprietary_name": "Verapamil Hydrochloride",
"active_ingred_unit": "mg/mL",
"application_number": "ANDA211015",
"marketing_category": "ANDA",
"nonproprietary_name": "Verapamil Hydrochloride",
"start_marketing_date": "20220111",
"active_numerator_strength": "2.5"
}See everything about verapamil hydrochloride.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.